| Q41112408 | Antiarrhythmic drug therapy for ventricular arrhythmias: current perspectives |
| Q94237892 | Arthur J. Moss (1931–2018) |
| Q52337729 | Bayesian decision making based on measurements containing errors. |
| Q40404084 | Current approaches in patients with ventricular tachyarrhythmias |
| Q51023897 | Epidemiologic assessment of angina before and after myocardial infarction: The Framingham study. |
| Q37448489 | Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar |
| Q58010915 | Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The autonomic tone and reflexes after myocardial infarction substudy) |
| Q33731644 | Management of ventricular arrhythmias: a trial-based approach |
| Q35272535 | Medical treatment after myocardial infarction. Results of studies using various methods |
| Q74011231 | Predicting severe ischemic events after uncomplicated myocardial infarction by exercise testing and rest and exercise radionuclide ventriculography |
| Q33568694 | Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator |
| Q74526537 | [Prognostic evaluation of post-infarction patients using two-dimensional echocardiography, late ventricular potentials and baroreflex sensitivity] |
| Q73092759 | [Risk stratification after acute myocardial infarction] |
| Q35370417 | beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study |